CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss			$ (4,052,621)	$ (847,485)
Adjustments to reconcile loss to net cash (used in) provided by operating activities:
Depreciation and amortization			839,353	340,217
Accretion of asset retirement obligation			58,449	54,813
Noncash operating lease expense			289,542	18,611
Share-based compensation			4,688,772	453,566
Accretion income from investment securities held to maturity			(222,440)
(Gain) loss on sale or disposal of property, plant and equipment, net	$ (8,216)	$ (16,252)	(8,716)	1,242
Gain on lease termination	(469,822)		(469,822)
Write-down of inventory to net realizable value				63,574
Change in allowance for credit losses			5,798	(30,746)
Other noncash items				(16,107)
Changes in operating assets and liabilities:
Accounts receivable			(804,211)	(175,748)
Inventories			(7,167,437)	324,264
Prepaid expenses and other current assets			(1,726,295)	(87,824)
IVA receivable and other assets, net			(500,128)	60,856
Accounts payable			2,672,335	889,242
Accrued liabilities			154,481	46,129
Accrued liabilities - directors			(51,757)	34,355
Royalties payable			74,011	(48,255)
Stock payable to directors				(38,542)
Net cash (used in) provided by operating activities			(6,220,686)	1,042,162
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from redemption of certificates of deposit				50,641
Purchases of investment securities held to maturity			(19,934,953)
Proceeds from sales of property, plant and equipment			8,716	314,125
Purchases of property, plant and equipment			(16,069,244)	(223,058)
Net cash (used in) provided by investing activities			(35,995,481)	141,708
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt			(98,756)	(71,139)
Proceeds from exercises of stock options			55,000
Treasury stock acquired			(409,246)
Proceeds from issuance of common stock, net of issuance costs			38,440,596
Proceeds from exercise of warrants			4,427,756
Net cash provided by (used in) financing activities			42,415,350	(71,139)
NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH			199,183	1,112,731
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD			18,270,898	11,954,635	$ 11,954,635
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD	$ 18,470,081	$ 13,067,366	18,470,081	13,067,366	$ 18,270,898
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid in cash			14,642	5,630
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Recognition of operating lease liability and right-of-use asset			$ 63,416	787,477
Equipment purchased with note payable				$ 402,722